| Name | Title | Contact Details |
|---|
BioInformatics is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quantum Group is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Quantum Group is based in Wellington, FL. You can find more information on Quantum Group at www.quantummd.com
Connecticut Hospital Association is a Wallingford, CT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Fresenius Medical Care is the world`s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure. We care for more than 300,000 patients in our global network of more than 3,500 dialysis clinics. At the same time, we operate ~ 40 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables. Our strategy is geared toward sustainable growth. We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality. Fresenius Medical Care`s corporate headquarters are in Bad Homburg v.d.H., Germany. The headquarters of North America are in Waltham, Massachusetts and the headquarters of Asia-Pacific are located in Hong Kong.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.